Navigation Links
Results of the GIANT trial reported at TCT 2013
Date:11/1/2013

SAN FRANCISCO, CA October 31, 2013 According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention (PCI) may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize thienopyridine blood thinning therapies such as clopidogrel.

Findings from the GIANT trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

The effectiveness of clopidogrel depends on activation to an active metabolite, principally via the CYP2C19 enzymatic pathway. Acute coronary syndrome patients that carry a CYP2C19 gene variant poorly metabolize the drug. These patients are known as slow responders and exhibit a higher one year risk of major ischemic events following PCI. Genetic tests can help identify a patient's CYP2C19 genotype, but it is unknown if on-line adjustment of thienopyridine therapy in the genetically slow-responder patient population may counteract this outcome.

The GIANT trial evaluated the clinical impact of CYP2C19 genetic profiling and compliance to an adjusted thienopyridine treatment. The primary endpoint was a composite of death, myocardial infarction, and stent thrombosis after one year in slow responder patients with appropriate therapy after genotyping, compared to non-slow responders.

The prospective, multicenter, single arm study enrolled 1,499 patients at the time of primary PCI (onset chest pain < 24 hours). Genetic profiling was performed within 48 hours after intervention to detect a loss of CYP2C19 gene function and identify a resistance to clopidogrel.

Strong recommendations for treatment adjustment were sent to investigators when patients were identified as slow responders.

Dual antiplatelet
'/>"/>

Contact: Judy Romero
jromero@crg.org
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. False-Positive Mammogram Results May Turn Out Not to Be: Study
2. Good intentions bring mixed results for Haitis disabled people
3. Presentation of 1-year IVAN and 2-year CATT study results
4. Groundbreaking Nigeria summit results in major commitment to reduce child deaths
5. Surprising results for use of dialysis for kidney failure in developing world
6. Stem Cell Study Shows Promising Results Against Heart Failure
7. Automated insulin dosage titration system demonstrates positive clinical study results
8. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
9. Tight Blood-Sugar Control Shows Mixed Results for Health of Kidneys: Study
10. ACP-New York State Chapter partnership results in patient safety organization recognition
11. Long-term testosterone treatment for men results in reduced weight and waist size
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... “ Nursing Homes are starting to supplant ... title of a recent April 2015 New York Times article. ... to the hospital, 20-plus years of research have documented the ... high-quality nursing homes are both safer for older patients and ... nursing homes varying widely, patients and family members may worry ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 While hair ... hair loss, a new pilot study conducted by a ... Surgery (ISHRS) has found hair follicle grafting can help ... research was partially funded by ISHRS, which offers research ... to hair restoration. , In the past decade, ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes extensive oil ... oil and gas investing, the substantial tax benefits available ... news, IRA investing, definitions and acronyms, info-graphics and educational ... experience is now in one central location, for the ... access 24 hours a day, 7 days a week. ...
(Date:5/27/2015)... NJ (PRWEB) May 27, 2015 ... Network (BCAN) , whose mission is to advance research, ... cancer, have joined forces to battle the fifth most ... in the bladder’s lining start to grow out of ... and their families at every stage of the cancer ...
(Date:5/27/2015)... May 27, 2015 Difass USA, a ... the U.S. with its first three flagship products, Dormiva™, ... purchase nationwide through http://www.difassusa.com . , A ... and productivity, but some people struggle with getting the ... is a sleep aid designed to help you fall ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... 9 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical ... therapeutics, today announced that Bruce A. Molitoris, M.D., ... Indiana University , will present data demonstrating ... disease (AKI and CKD, respectively) of an animal ...
... Prevention Departments are Under-financed, Under-staffed; Patient Safety Weakened , ... are cutting staff, resources and education for infection prevention ... infections is increasing, according to a report released today ... Epidemiology (APIC). , , The "2009 ...
... Rebuild After Physical Activity , , COLUMBUS, Ohio, June 9 ... (NYSE: ABT ) today announced the EAS(R) ... on the go refuel after physical activity. The ready-to-drink sports nutrition ... , , To view the Multimedia News Release, go to: ...
... and dental expand cost-effective solutions for today,s challenging economy ... BlueCross BlueShield (Empire) today announced approval by the New ... Disability insurance as part of their broad benefit portfolio. ... Disability Insurance Company, this addition makes Empire a leading ...
... brain may help you find solutions while asleep, study suggests ... need to solve a problem, sleep on it, researchers suggest. ... University of California, San Diego, researchers say that rapid ... forming new associative networks in the brain. , "We found ...
... June 9 Par Pharmaceutical Companies, Inc. (NYSE: ... spray to the trade. Calcitonin-salmon nasal spray is a ... sales of Miacalcin were approximately $112 million in 2008, according ... Important information about calcitonin-salmon nasal spray , , ...
Cached Medicine News:Health News:Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit 2Health News:Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit 3Health News:Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit 4Health News:Hospital Infection Prevention Resources Cut, Study Says 2Health News:Hospital Infection Prevention Resources Cut, Study Says 3Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 2Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 3Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 4Health News:Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging 5Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 2Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 3Health News:Empire BlueCross BlueShield Adds Life Insurance, Becomes Full-Service Benefits Provider 4Health News:Got a Problem? Think About It Overnight 2Health News:Par Pharmaceutical Begins Shipment of Generic Miacalcin(R) 2
(Date:5/27/2015)... -- With all the daily obstacles facing physicians these days, ... patients healthy should be easy. Unfortunately, it isn,t always. ... Act continues to affect the way physicians are reimbursed ... important than ever that medical practices have open and ... for patient care. Each year, cloud-based services ...
(Date:5/27/2015)... Tout voyageur ... Il nuit sérieusement à la productivité. Il ... réunions de mi-journée et vous empêche de ... dans votre chambre d,hôtel. Même une semaine ... de vous empêcher de tenir compagnie à ...
(Date:5/27/2015)... 2015 Research and Markets ... the "2015 Strategies in the European Coagulation ... This comprehensive five-country report contains 500 pages, ... suppliers and potential market entrants identify and evaluate ... market during the next five years. ...
Breaking Medicine Technology:Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 4European Coagulation Testing Market Strategies 2015 2
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
The Multi-Purpose Medical-Surgical Shoe...
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... use as a non-reactive quality assurance reagent in ... gondii (TOXO IgG and TOXO IgM), IgG and ... rubella IgM), IgG and IgM antibodies to cytomegalovirus ... antibodies to herpes simplex virus types 1 and ...
Medicine Products: